Mersana Therapeutics
MRSN
MRSN
69 hedge funds and large institutions have $203M invested in Mersana Therapeutics in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
9% less funds holding
Funds holding: 76 → 69 (-7)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
Holders
69
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$8.95M | |
| 2 | +$5.29M | |
| 3 | +$4.58M | |
| 4 |
Millennium Management
New York
|
+$4.36M |
| 5 |
O
OrbiMed
New York
|
+$1.04M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$4.87M | |
| 3 | -$2.66M | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.25M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.98M |